Remifentanil use for procedural sedation and analgesia in the emergency department
Completed
- Conditions
- discharge from hospitalrecovery time100407951000752110005942
- Registration Number
- NL-OMON40569
- Lead Sponsor
- Albert Schweitzer Ziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
All the patients who need procedural sedation and analgesia at the emergency department or the observatorium of the Albert Schweitzer hospital location Dordwijk in Dordrecht, age 18 years and older, classified as ASA I en II.
Exclusion Criteria
Age under 18 years, hemodynamic and/or respiratory instable, classified as ASA III, IV and V, suspicion of elevated intra-cranial pressure, pregnancy, use of opiates at home, opiates administered before PSA procedure started (in the ambulance, on arrival at the emergency department), intoxication, known allergy for fentanyl propofol remifentanil soy or chicken proteins
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Primary outcome:<br /><br>- The recovery time ( time between last dose PSA medication and full recovery<br /><br>of the patient).</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary outcome<br /><br>- Adverse effects, complications.<br /><br>- Succesfull interventions.<br /><br>- Satisfaction of the specialist about performing the intervention.<br /><br>- Adequate analgesia during procedure.<br /><br>- Satisfaction patient.</p><br>